Exploring the anti-obesity potential of Ailanthus excelsa Roxb in vitro enzymatic inhibition and computational pharmacology insights

This study explores the potential of Ailanthus excelsa Roxb. for managing obesity by evaluating its effects on key metabolic enzymes. We evaluated a hydroalcoholic extract and its fractions for their ability to modulate important metabolic enzymes, porcine pancreatic lipase, HMG-CoA reductase, α-glucosidase, and α-amylase activities. Our methodology integrated in vitro enzymatic assays with cluster analysis (MCODE, ClueGO, and Cluepedia) and network pharmacology to elucidate interactions between metabolites and target enzymes. Protein-protein interaction (PPI) analysis, consisting of a network with 51 nodes and 264 edges, was performed using the CytoNCA plugin to calculate topological parameters. Key targets were identified based on degree centrality, including ADIPOQ, PPARA, PPARG, IL6, TNF, and AKT1. Cluster analysis of the PPI networks, conducted using the MCODE plugin, highlighted a top cluster with a high score of 22.82. Network pharmacology has identified key targets associated with obesity, including HK1, HK2, PIK3CA, AKT1, MTOR, CD36, ACACB, SLC2A4, CPTIA, INSR, ACACA, FASN, and ADIPOQ. These targets are linked to highly modulated metabolic pathways. Isoquercetin shows significant binding affinities: - 7.11 for HMG-CoA Reductase (PDB ID: 1HW9), -9.96 for lipase (PDB ID: 1LPB), - 8.96 for α-amylase, and - 10.41 for α-Glucosidase (PDB ID: 3A47). The ethyl acetate fractions exhibit notable inhibition of Porcine Pancreatic lipase (IC<sub>50</sub>: 56.25 ± 4.85 µg/mL) and HMG-CoA reductase (IC<sub>50</sub>: 108.27 ± 3.38 µg/mL), α-glucosidase (IC<sub>50</sub>: 117.08 ± 3.28 µg/mL), and α-amylase (IC<sub>50</sub>: 125.93 ± 2.29 µg/mL). Moreover, metabolites showed stronger binding affinities to all four enzymes than reference molecules. By integrating in vitro assays with molecular modeling, this study highlights the promising potential of A. excelsa and its fractions in obesity management, offering valuable insights into its therapeutic applications.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-09-24
DOI
https://doi.org/10.1038/s41598-025-14420-2
Citations
1
Primary Topic
Insect Utilization and Effects
Type
article
Field-Weighted Citation Impact
1.67

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the anti-obesity potential of Ailanthus excelsa Roxb in vitro enzymatic inhibition and computational pharmacology insights

Shankar Gharge, Jagdish Chand, M. B. Patil, Sabry Mohamed Attia et al.
1 citations
Scientific Reports
Insect Utilization and Effects
1.67
article

Exploring the anti-obesity potential of Ailanthus excelsa Roxb in vitro enzymatic inhibition and computational pharmacology insights

Shankar Gharge, Jagdish Chand, M. B. Patil, Sabry Mohamed Attia, Sheikh F. Ahmad, Shriram D. Ranade, Sachin Gudasi, Talha Bin Emran, Hannah Lalengzuali Fanai
article en
1 citations

Abstract

This study explores the potential of Ailanthus excelsa Roxb. for managing obesity by evaluating its effects on key metabolic enzymes. We evaluated a hydroalcoholic extract and its fractions for their ability to modulate important metabolic enzymes, porcine pancreatic lipase, HMG-CoA reductase, α-glucosidase, and α-amylase activities. Our methodology integrated in vitro enzymatic assays with cluster analysis (MCODE, ClueGO, and Cluepedia) and network pharmacology to elucidate interactions between metabolites and target enzymes. Protein-protein interaction (PPI) analysis, consisting of a network with 51 nodes and 264 edges, was performed using the CytoNCA plugin to calculate topological parameters. Key targets were identified based on degree centrality, including ADIPOQ, PPARA, PPARG, IL6, TNF, and AKT1. Cluster analysis of the PPI networks, conducted using the MCODE plugin, highlighted a top cluster with a high score of 22.82. Network pharmacology has identified key targets associated with obesity, including HK1, HK2, PIK3CA, AKT1, MTOR, CD36, ACACB, SLC2A4, CPTIA, INSR, ACACA, FASN, and ADIPOQ. These targets are linked to highly modulated metabolic pathways. Isoquercetin shows significant binding affinities: - 7.11 for HMG-CoA Reductase (PDB ID: 1HW9), -9.96 for lipase (PDB ID: 1LPB), - 8.96 for α-amylase, and - 10.41 for α-Glucosidase (PDB ID: 3A47). The ethyl acetate fractions exhibit notable inhibition of Porcine Pancreatic lipase (IC<sub>50</sub>: 56.25 ± 4.85 µg/mL) and HMG-CoA reductase (IC<sub>50</sub>: 108.27 ± 3.38 µg/mL), α-glucosidase (IC<sub>50</sub>: 117.08 ± 3.28 µg/mL), and α-amylase (IC<sub>50</sub>: 125.93 ± 2.29 µg/mL). Moreover, metabolites showed stronger binding affinities to all four enzymes than reference molecules. By integrating in vitro assays with molecular modeling, this study highlights the promising potential of A. excelsa and its fractions in obesity management, offering valuable insights into its therapeutic applications.

Scientific ReportsVol. 15(1)
JSS Academy of Higher Education and Research (IN), University of Louisville (US), King Saud University (SA), KLE Academy of Higher Education and Research (IN)
King Saud University
Openalex Percentile: Top 14%
Insect Utilization and Effects
1.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.